Filter
7632
Filtered Results: 7632
Text search:
number
of
patients
Featured
Recommendations
731
New Publications
1929
Language
Document type
No document type
4300
Studies & Reports
1174
Guidelines
1075
Manuals
385
Strategic & Response Plan
228
Fact sheets
168
Training Material
127
Situation Updates
98
Resource Platforms
24
Infographics
19
Online Courses
17
Brochures
15
Dashboards/Maps
1
Videos
1
Countries / Regions
India
433
Global
253
Kenya
212
South Africa
212
Sierra Leone
194
Liberia
178
Western and Central Europe
162
Ethiopia
152
Uganda
139
Nigeria
134
Africa
115
Malawi
114
Nepal
112
Latin America and the Carribbean
108
Tanzania
107
Zambia
97
Rwanda
96
Bangladesh
92
Myanmar / Burma
86
Ghana
85
Syria
82
Ukraine
79
Namibia
63
Philippines
57
Congo, Democratic Republic of
56
Eastern Europe
56
Russia
55
Guinea
54
Zimbabwe
48
West and Central Africa
48
South–East Asia Region
48
Lesotho
47
Cambodia
46
Mozambique
46
East and Southern Africa
45
Middle East and North Africa
44
Asia
43
South Sudan
41
Haiti
40
Germany
38
Indonesia
35
Senegal
34
Brazil
32
Botswana
31
Burkina Faso
30
Eastern Europe and Central Asia
29
Cameroon
27
Yemen
24
Benin
22
Eswatini/ Swaziland
21
Colombia
19
Venezuela
19
Pakistan
16
Western Pacific Region
16
USA
15
Madagascar
15
Mali
13
Central African Republic
13
Iraq
12
Afghanistan
12
Albania
12
Tajikistan
12
Thailand
11
Sudan
11
Peru
11
Georgia
11
Somalia
10
Lebanon
10
Sri Lanka
10
Jordan
9
Chile
9
Palestine
9
Southern Africa
9
Laos
9
Moldova
9
Vietnam
9
Côte d’Ivoire / Ivory Coast
8
Angola
8
Paraguay
8
North America
8
United Kingdom
8
China
7
North Macedonia
6
Bolivia
6
Armenia
6
Turkey
5
Chad
5
Argentina
5
Ecuador
5
Mexico
5
Kazakhstan
5
Jamaica
5
France
5
Guinea-Bissau
4
Togo
4
Gambia
4
Hungary
4
Bhutan
4
Poland
4
Kyrgyzstan
4
Spain
4
Saudi Arabia
3
Niger
3
Singapore
3
Papua New Guinea
3
Serbia
3
El Salvador
3
Greece
3
Libya
3
Canada
3
Timor Leste/ East Timor
3
Romania
3
Uzbekistan
3
Mauritius
3
Morocco
2
Egypt
2
Ireland
2
Switzerland
2
Burundi
2
Honduras
2
Guatemala
2
Other region
2
Bulgaria
2
Lithuania
2
Slovakia
2
Iran
2
Australia
2
Portugal
2
Malaysia
1
Mauritania
1
Austria
1
Nicaragua
1
Fiji
1
Solomon Islands
1
North Korea
1
Mongolia
1
Congo-Brazzaville
1
Qatar
1
Estonia
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
Belgium
1
Maldives
1
Tunisia
1
Norway
1
Belarus
1
French Guyana
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
2849
Clinical Guidelines
692
Public Health
421
Women & Child Health
297
Key Resources
234
Capacity Building
163
Pharmacy & Technologies
102
Annual Report MEDBOX
2
Toolboxes
COVID-19
848
Mental Health
613
HIV
603
TB
496
Ebola
315
Caregiver
257
Rapid Response
255
AMR
248
NTDs
220
Conflict
180
NCDs
175
Pharmacy
166
Disability
146
Refugee
123
Planetary Health
122
Global Health Education
76
Cholera
64
Natural Hazards
58
Zika
49
Specific Hazards
44
Health Financing Toolbox
41
Polio
38
Social Ethics
26
Typhoon
3
South Sudan
1
Health Financing
1
PQDx 0197-045-00 WHO
PQDx PR
March /2016, version 2.0
Patients with retreatment tuberculosis (TB) represent those
who have been treated previously for onemonth ormorewith
anti-TB drugs and who have been diagnosed once again with
the disease.These patients<...
May 9, 2022.Since the onset of the COVID-19 pandemic, a large number of clinical trials have been planned and developed to assess the effectiveness...
The alarming rise in the worldwide prevalence of obesity and associated type 2 diabetes mellitus (T2DM) have reached epidemic portions. Diabetes in its many forms and T2DM have different physiological backgrounds and are difficult to classify. Baria...
Hep B Help colates a number of Hepatitis B fact sheet and other resources for patient education.
Accessed 13th ... November 2015.
Hypertension is the number one health related risk factor in India, with the largest contribution to burden of disease and mortality. It contributes to an estimated 1.6 million deaths, due to ischem...
Rabies is a public health problem in Asia and vaccine affordability is an issue.
There is no reduction in the number of persons seeking post-exposure prophylaxis.
The high cost ... cell culture vaccines for intramuscular use is a limiting factor.
Intradermal rabies vaccination offers cost-effective alternative to intramuscular.
WHO recommended one week intradermal schedule will ensure good patient compliance.
mBio, Vol. 6 Issue 2, March/April 2015
Available evidence demonstrates that direct patient contact and contact with infectious body fluids are the primary modes for Ebola virus transmission, but this is based on a limited ... of studies. In this review, the authors address what we know and what we do not know about Ebola virus transmission. They also hypothesize that Ebola viruses have the potential to be respiratory pathogens with primary respiratory spread.
In the face of rapid increases in the number of hospitalizations due to COVID-19 in Latin America and the Caribbean, coupled with shortages ... human and material resources, including medical equipment and gases, there is a need to redesign models of care in the Region to optimize available resources and ensure that more patients receive the quantity and quality of oxygen they need. Oxygen is included in the World Health Organization’s list of essential medicines and is used to care for patients at all levels of integrated health services networks. The efficacy of oxygen use in the treatment of patients with respiratory conditions caused by COVID-19 has been demonstrated, but there is great opportunity to improve the effectiveness of its use if it is used in a rational, sustainable, and safe way. Bearing in mind that the efficacy of a health technology is measured by its benefit under actual conditions of use, practical actions can be taken to improve the use of medical oxygen and avoid oxygen shortages. A drug is considered to be used rationally when patients receive it according to their clinical needs, in doses appropriate to their individual needs, for an appropriate period, and at a low cost to them and their community. By providing instruction on the rational use of oxygen and promoting it, negative repercussions can be avoided, such as loss of efficacy as a result of activities related to oxygen storage, distribution, and administration. Rational use of oxygen also involves controlling waste due to leaks in storage and distribution systems, use of gas at incorrect pressures, use of incorrectly adjusted flowmeters, and disconnections, among other problems. Another aspect to consider is the provision of adequate technical support for all oxygen production systems, in terms of maintenance and calibration, availability of electrical energy, and specific knowledge about these systems. For these reasons, a set of guidelines has been put together for the development of an efficient management system to deal with situations of oxygen scarcity, both now and in the future.
Sleeping sickness is a neglected tropical disease affecting rural communities in sub-Saharan Africa. The reduction in the number of reported cases in recent years indicates that disease transmission...
This report reviews and analyses the Affordable Medicines Programme, which was introduced in Ukraine in April 2017 to provide patients with improved access to 23 outpatient medicines for the treatment of...
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number ... human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recognition of signs and symptoms, which are often nonspecific, and it can mimic other acute febrile syndromes. Early detection of suspected or confirmed cases, monitoring of vital signs, life support measures, and treatment of acute kidney failure continue to be the recommended strategies for case management. This report is the result of discussions among experienced specialists in the Americas on the clinical management of yellow fever patients, especially during outbreaks and epidemics, in the context of current medical and scientific evidence and taking into account the technical guidelines already available in the countries of the Region. It includes flowcharts for initially addressing patients with clinical suspicion of yellow fever and proposes a minimum package of laboratory tests that may be useful in contexts where resources are limited. In addition, it considers aspects of health system organization for dealing with yellow fever outbreaks and epidemics.
Cholera is a transmissible diarrhoeal infection caused by Vibrio cholerae. Endemic and/or epidemic in over 40 countries (mainly in Africa and Asia), cholera continues to be a major global public health issue.
The World Health Organization (WHO) estimates that the ... of cases reported worldwide represents in reality only 5 to 10% of actual cases.
This guide is intended for medical and non-medical staff responding to a cholera outbreak. It attempts to provide concrete answers to the questions and problems faced by staff, based on the recommendations of reference organisations, such as WHO and UNICEF, as well as Médecins Sans Frontières’ experience in the field.
It is divided into 8 chapters. Chapter 1, Cholera overview, outlines the epidemiological and clinical features of cholera. Chapter 2, Outbreak investigation, explains the method and stages of a field investigation, from the alert to implementation of initial activities. Chapter 3, Cholera control measures, details measures and tools to prevent and/or control cholera transmission and mortality in populations affected, or at risk of being affected, by an epidemic (curative care, prevention means and health promotion activities). Chapter 4, Strategies for epidemic response, addresses the roll-out strategies of the measures described in Chapter 3 which depend on context (e.g. urban, rural, endemic, non-endemic setting, etc.), resources and particular constraints. Chapter 5, Cholera case management, details the different stages of cholera treatment, from diagnosis through to cure.
Chapter 6, Setting up cholera treatment facilities, focuses on the installation of treatment facilities that vary in size and complexity according to operational requirements (treatment centres and units and oral rehydration points). Chapter 7, Organisation of cholera treatment facilities, describes the organisation of these specialized facilities in terms of human resources, supply, water, hygiene and sanitation, etc. Chapter 8, Monitoring and evaluation, presents the key data to be collected and analysed during an epidemic to facilitate a tailored response and evaluate its quality and effectiveness.
The guide includes various practical tools in the appendices to facilitate activities (e.g. water quality tests, job descriptions, documents, etc.). Moreover, the toolbox also contains additional tools in editable formats (individual patient file, cholera case register, pictograms).
Despite all efforts, it is possible that certain errors may have been overlooked in this guide. Please inform the authors of any errors detected.
To ensure that this guide continues to evolve while remaining adapted to field realities, please send any comments or suggestions.
Background: COVID-19 is a global public health crisis that affects all sectors; studying the impact of this pandemic on the delivery of cardiology services in Africa is crucial as COVID-19-related c...
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a sel...
Objective: The study aimed to describe the current epidemiological, clinical and immunological profile of newly
detected HIV - positive patients in Northern Benin by 2016. Methods: It was a prospec...
Healthcare 2020, 8(1), 26; https://doi.org/10.3390/healthcare8010026
The current article is an integrative and analytical literature review on the concept and meaning of empathy in health and social care professionals. Empat...
Online learning for clinical management staff of respiratory diphtheria in Cox's Bazar, Bangladesh.
In December 2017, the WHO Health Emergencies Programme launched an online learning for clinical staff on respiratory diphtheria through the OpenWHO....
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment ... people infected with the Ebola virus:
BCX4430 (Biocryst);
Brincidofovir (Chimerix);
Favipiravir (Fujifilm Corporation/Toyama);
TKM-100802 (Tekmira);
AVI-7537 (Sarepta);
ZMapp (Leafbio Inc.);
Anti-Ebola F(ab’)2 (Fab’entech).
The amount of information available for the seven treatments is highly variable. For some compounds there is no data from use in human subjects available. A small number of treatments have been administered to patients in the current Ebola outbreak as compassionate use. Finally, there are also medicines included in this review that have already been studied in humans, albeit for the treatment of other viral diseases.
